UPMC: Monoclonal Antibody Treatment Reduces Risk Of Hospitalizations

Name: UPMC: Monoclonal Antibody Treatment Reduces Risk Of Hospitalizations
Uploaded: 2021-03-26T17:19:13+00:00
Duration: P29S
Description: UPMC announced Friday that they are making significant headway with a developing COVID-19 treatment: monoclonal antibodies.

Video Credit: KDKA CBS 2 Pittsburgh - Duration: 00:29s - Published on March 26, 2021

UPMC: Monoclonal Antibody Treatment Reduces Risk Of Hospitalizations

UPMC announced Friday that they are making significant headway with a developing COVID-19 treatment: monoclonal antibodies.

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Daily Covid-19 Minute: Regeneron’s Antibody Cocktail [Video]

Daily Covid-19 Minute: Regeneron’s Antibody Cocktail

Drug maker Regeneron has just released data from their phase 3 clinical trial showing their antibody cocktail, when given to high-risk, non-hospitalized covid patients, reduces the risk of..

Credit: CBS 62 Detroit Duration: 01:02Published on March 26, 2021

UPMC: Monoclonal Antibody Treatment Reduces Risk Of Hospitalizations

You Might Like

Related videos from verified sources